Elagolix

Overview

Elagolix is an orally active, highly effective, selective and non-peptide gonadotropin-releasing hormone receptor ( GnRH receptor ) antagonist (K D = 54 pM) and NFAT inhibitor, which can be used to study pain related to endometriosis.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cancer | Products > Signaling Pathways > GnRH Receptor | Products > Signaling Pathways > Nuclear Factor of activated T Cells (NFAT)

Product Information

• Catalog No.: HY-115633
• CAS No.: 2323071-30-1
• Molecular Formula: C32H30F5N3O5
• Molecular Weight: 631.59
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source